Cardiac Valve Diseases and Treatments
Cardiac Valve Diseases and Treatments is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 77k research works in it since 1950. 12.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management and treatment of valvular heart disease, with a particular emphasis on transcatheter and surgical aortic-valve replacement, evaluation of valvular regurgitation using echocardiography, guidelines for prosthetic valve assessment, and the impact of various risk models on outcomes in cardiac surgery.
- Transcatheter Aortic-Valve Replacement
- Surgical Aortic-Valve Replacement
- Valvular Regurgitation
- Echocardiography Guidelines
- Aortic Stenosis
- Mitral Regurgitation
- Prosthetic Valves Evaluation
- Heart Valve Surgery
- EuroSCORE
- Cardiac Surgery Risk Models
- Research works
- 77k fractional, since 1950
- In the world top 10%
- 9.7k per year above
- Top-10% rate
- 12.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiac Valve Diseases and Treatments research?
By volume, the United States and China publish the most (4.5k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 4.5k works
- 2 China 1.2k works
- 3 Japan 975 works
- 4 Italy 938 works
- 5 Germany 930 works
- 6 United Kingdom 606 works
- 7 Spain 543 works
- 8 India 439 works
- 9 France 431 works
- 10 Canada 416 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiac Valve Diseases and Treatments research?
By volume in 2022–2025, Cleveland Clinic publishes the most Cardiac Valve Diseases and Treatments research, followed by Mayo Clinic in Arizona and Mayo Clinic.
By volume, 2022–2025
- 1 Cleveland ClinicUnited States 158 works
- 2 Mayo Clinic in ArizonaUnited States 81 works
- 3 Mayo ClinicUnited States 73 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 73 works
- 5 Icahn School of Medicine at Mount SinaiUnited States 52 works
- 6 Massachusetts General HospitalUnited States 50 works
- 7 Sichuan UniversityChina 48 works
- 8 Harvard UniversityUnited States 46 works
- 9 Houston MethodistUnited States 45 works
- 10 Columbia University Irving Medical CenterUnited States 44 works
Who are the leading researchers in Cardiac Valve Diseases and Treatments?
The most-cited researchers publishing on Cardiac Valve Diseases and Treatments include Valentı́n Fuster, Winfried März and Victor Aboyans.
- 1 Valentı́n Fuster United States 5.4k citations
- 2 Winfried März Germany 5.2k citations
- 3 Victor Aboyans France 4.9k citations
- 4 E. Murat Tuzcu United States 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiac Valve Diseases and Treatments research done?
The largest centres of Cardiac Valve Diseases and Treatments research in 2022–2025 are New York (United States), Beijing (China), London (United Kingdom) and Cleveland (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Bad Oeynhausen, Carnaxide and San Donato Milanese.
Largest cities, 2022–2025
Where it is the local speciality
- Bad OeynhausenDE · 27.5 works81×
- CarnaxidePT · 21.3 works64×
- San Donato MilaneseIT · 21.8 works49×
Location quotient: how much more of its research is in Cardiac Valve Diseases and Treatments than the world average.
Where is the best place to study Cardiac Valve Diseases and Treatments?
Among universities, judged by research, Institut universitaire de cardiologie et de pneumologie de Québec, University of Bern and Humanitas University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Institut universitaire de cardiologie et de pneumologie de QuébecCanada | 55.7 | 18.4% | 79.9× | 23 | +38.1% |
| 2 | University of BernSwitzerland | 54.2 | 33.0% | 3.8× | 23 | +58.9% |
| 3 | Humanitas UniversityItaly | 52.4 | 17.7% | 9.1× | 10 | +103.8% |
| 4 | Vita-Salute San Raffaele UniversityItaly | 50.3 | 13.9% | 13.1× | 25 | -10.6% |
| 5 | St. Marianna University School of MedicineJapan | 50.2 | 6.6% | 24.1× | 16 | +189.7% |
| 6 | Medical University of ViennaAustria | 50.0 | 12.2% | 7.5× | 33 | +72.4% |
| 7 | Icahn School of Medicine at Mount SinaiUnited States | 49.1 | 12.7% | 7.4× | 52 | +46.3% |
| 8 | Université LavalCanada | 46.9 | 22.1% | 5.3× | 31 | +20.8% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 46.2 | 13.0% | 5.1× | 73 | +70.0% |
| 10 | Semmelweis UniversityHungary | 44.9 | 10.9% | 8.0× | 23 | +56.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiac Valve Diseases and Treatments research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiac Valve Diseases and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.